3rd Circ. Upholds Dismissal Of Lipitor Pay-To-Delay Case
The Third Circuit on Thursday backed the dismissal of an antitrust suit alleging Pfizer Inc. and Ranbaxy Laboratories Ltd. conspired to delay the market entry of a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article